{
  "ptid_time": "009_S_1030_2010-12-08",
  "img_path": "/data/qiuhui/data/adni/images/009_S_1030/2010-12-08/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 58,688 mm³, 52.4% above the reference mean. With a Z-score of 1.25 (89.5th percentile), this represents mild enlargement; hippocampal volume measures 7,686 mm³, 1.7% above the reference mean. With a Z-score of 0.16 (56.5th percentile), this represents normal volume ; whole brain volume measures 1,054,300 mm³, 2.3% below the reference mean. With a Z-score of -0.30 (38.1th percentile), this represents normal volume ; entorhinal cortex volume measures 4,039 mm³, 1.5% below the reference mean. With a Z-score of -0.10 (45.9th percentile), this represents normal volume ; fusiform gyrus volume measures 11,612 mm³, 38.4% below the reference mean. With a Z-score of -3.27 (0.1th percentile), this represents profound atrophy; middle temporal gyrus volume measures 14,717 mm³, 31.0% below the reference mean. With a Z-score of -2.79 (0.3th percentile), this represents significant atrophy. ",
  "text_data": "Age is 71.4 years. Gender is Male. Education: 20 years. Handedness: Right. Race: White. MMSE: 23.0. MoCA: 19.0. Logical Memory: 8.0. APOEε4 alleles: 0.0. Biomarker levels: Florbetapir (AV45): 1.33 SUVR (moderate elevated); Amyloid beta: 985.80 pg/mL (normal ); Total tau: 406.30 pg/mL (significant elevated); Phosphorylated tau: 40.35 pg/mL (significant elevated). ",
  "true_diagnosis": "Diagnosis: AD.",
  "gpt_diagnosis": "**Reasoning:** The patient shows significant atrophy in the fusiform gyrus and middle temporal gyrus, along with mild ventricular enlargement, suggesting neurodegeneration. Elevated T-tau and P-tau with normal Aβ indicate a non-Alzheimer’s tauopathy (e.g., primary age-related tauopathy or PART). Cognitive scores (MMSE 23, MoCA 19) are below normal, supporting cognitive impairment.  \n\n**Diagnosis:** **Mild Cognitive Impairment (MCI)** (likely due to tauopathy rather than Alzheimer’s pathology given Aβ-normal but tau-elevated profile).  \n\n**Confidence:** **Medium** (clear structural and biomarker abnormalities, but atypical Alzheimer’s profile lowers certainty; clinical correlation needed for specific tauopathy subtype).",
  "timestamp": "2025-07-25T22:14:46.947695"
}